Verona Pharma Plc Stock Analysis
| VRNA Stock | USD 60.29 1.75 2.99% |
Verona Pharma PLC is fairly valued with Real Value of 59.24 and Hype Value of 57.42. The main objective of Verona Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Verona Pharma PLC is worth, separate from its market price. There are two main types of Verona Pharma's stock analysis: fundamental analysis and technical analysis.
The Verona Pharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Verona Pharma's ongoing operational relationships across important fundamental and technical indicators.
Verona |
Verona Stock Analysis Notes
About 35.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 2.16. Verona Pharma PLC had not issued any dividends in recent years. Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. Verona Pharma is traded on NASDAQ Exchange in the United States. For more information please call David PharmD at 44 20 3283 4200 or visit https://www.veronapharma.com.Verona Pharma PLC Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Verona Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Verona Pharma PLC or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Verona Pharma PLC appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 42.28 M. Net Loss for the year was (173.42 M) with profit before overhead, payroll, taxes, and interest of 39.7 M. | |
| Verona Pharma PLC currently holds about 111.51 M in cash with (122.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| Verona Pharma PLC has a poor financial position based on the latest SEC disclosures | |
| Over 86.0% of the company outstanding shares are owned by institutional investors |
Verona Pharma PLC Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Verona Pharma previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Verona Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.03 B.Technical Drivers
As of the 4th of April, Verona Pharma has the Coefficient Of Variation of 898.13, risk adjusted performance of 0.1173, and Semi Deviation of 3.26. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verona Pharma PLC, as well as the relationship between them.Verona Pharma PLC Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Verona Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Verona Pharma PLC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Verona Pharma PLC Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Verona Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Verona Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Verona Pharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Verona Pharma Outstanding Bonds
Verona Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Verona Pharma PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Verona bonds can be classified according to their maturity, which is the date when Verona Pharma PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Verona Pharma Predictive Daily Indicators
Verona Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Verona Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Verona Pharma Forecast Models
Verona Pharma's time-series forecasting models are one of many Verona Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Verona Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Verona Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Verona Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Verona shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Verona Pharma. By using and applying Verona Stock analysis, traders can create a robust methodology for identifying Verona entry and exit points for their positions.
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. Verona Pharma is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Verona Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Complementary Tools for Verona Stock analysis
When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |